| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CFO | President And COO
1 company
Trimarchi Thomas is a President And CFO at BBIO. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $26.9M at current prices.
Our model assigns Trimarchi Thomas a below-average insider score of 25/100, based on 3 past trades. On a 3-month view, 0.0% of the rated trades came out ahead, averaging -26.8% over three months.
Trimarchi Thomas's largest disclosed position is in BBIO as President And CFO, worth about $26.9M. The recent filings there lean toward selling, a net 103,775 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | BBIO Bridgebio Pharma, Inc. | President And CFO | Sell | 13,651 | $65.08 | $888,419.17 | -3.7% | +22.3% | - | |
| Feb 17, 2026 | BBIO Bridgebio Pharma, Inc. | President And CFO | Sell | 13,600 | $74.72 | $1,016,147.12 | -3.9% | -13.9% | - | |
| Nov 17, 2025 | BBIO Bridgebio Pharma, Inc. | President And CFO | Sell | 16,934 | $66.46 | $1,125,404.42 | -4.2% | +13.4% | - | |
| Aug 21, 2025 | BBIO Bridgebio Pharma, Inc. | President And CFO | Sell | 42,237 | $49.48 | $2,090,081.05 | -9.1% | +30.5% | +62.3% | |
| Aug 18, 2025 | BBIO Bridgebio Pharma, Inc. | President And CFO | Sell | 17,353 | $50.23 | $871,722.42 | -3.6% | +36.5% | +69.3% |